These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

785 related items for PubMed ID: 10666807

  • 1. Erythema migrans and serodiagnosis by enzyme immunoassay and immunoblot with three borrelia species.
    Stanek G, Breier F, Menzinger G, Schaar B, Hafner M, Partsch H.
    Wien Klin Wochenschr; 1999 Dec 10; 111(22-23):951-6. PubMed ID: 10666807
    [Abstract] [Full Text] [Related]

  • 2. Comparison of different Borrelia burgdorferi sensu lato strains for detection of immune response in patients with erythema migrans.
    Merljak Skocir L, Ruzić-Sabljić E, Maraspin-Carman V, Lotric-Furlan S, Logar M, Strle F.
    Int J Med Microbiol; 2008 Jul 10; 298(5-6):493-504. PubMed ID: 17892971
    [Abstract] [Full Text] [Related]

  • 3. Immunoblot analysis of the seroreactivity to recombinant Borrelia burgdorferi sensu lato antigens, including VlsE, in the long-term course of treated patients with erythema migrans.
    Glatz M, Fingerle V, Wilske B, Ambros-Rudolph C, Kerl H, Müllegger RR.
    Dermatology; 2008 Jul 10; 216(2):93-103. PubMed ID: 18216470
    [Abstract] [Full Text] [Related]

  • 4. Antibody responses to borrelia IR(6) peptide variants and the C6 peptide in Swedish patients with erythema migrans.
    Tjernberg I, Sillanpää H, Seppälä I, Eliasson I, Forsberg P, Lahdenne P.
    Int J Med Microbiol; 2009 Aug 10; 299(6):439-46. PubMed ID: 19138558
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Skin manifestations of Lyme borreliosis in patients at the 1st Dermato-venereologic Clinic of Comenius University Medical School in Bratislava 1996-1998].
    Svecová D, Buchvald J, Oprsalová K, Dolezalová A.
    Epidemiol Mikrobiol Imunol; 2000 Aug 10; 49(3):115-22. PubMed ID: 11040493
    [Abstract] [Full Text] [Related]

  • 9. Clinical relevance of different IgG and IgM serum antibody responses to Borrelia burgdorferi after antibiotic therapy for erythema migrans: long-term follow-up study of 113 patients.
    Glatz M, Golestani M, Kerl H, Müllegger RR.
    Arch Dermatol; 2006 Jul 10; 142(7):862-8. PubMed ID: 16847202
    [Abstract] [Full Text] [Related]

  • 10. Has the presence or absence of Borrelia burgdorferi sensu lato as detected by skin culture any influence on the course of erythema migrans?
    Logar M, Lotric-Furlan S, Maraspin V, Cimperman J, Jurca T, Ruzić-Sabljić E, Strle F.
    Wien Klin Wochenschr; 1999 Dec 10; 111(22-23):945-50. PubMed ID: 10666806
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Lymphoproliferative responses to Borrelia burgdorferi in patients with erythema migrans, acrodermatitis chronica atrophicans, lymphadenosis benigna cutis, and morphea.
    Buechner SA, Lautenschlager S, Itin P, Bircher A, Erb P.
    Arch Dermatol; 1995 Jun 10; 131(6):673-7. PubMed ID: 7778918
    [Abstract] [Full Text] [Related]

  • 14. [Criteria for evaluation of immunoblots using Borrelia afzelii, Borrelia garinii and Borrelia burgdorferi sensu stricto for diagnosis of Lyme borreliosis].
    Honegr K, Havlasová J, Gebouský P, Dostál V, Pellantová V, Skrabková Z, Hulínská D.
    Epidemiol Mikrobiol Imunol; 2001 Nov 10; 50(4):147-56. PubMed ID: 11769176
    [Abstract] [Full Text] [Related]

  • 15. [Comparison of test with antigen VlsE (C6) with tests with recombinant antigens in patients with Lyme borreliosis].
    Zajkowska JM, Kondrusik M, Pancewicz SA, Grygorczuk S, Jamiołkowski J, Stalewska J.
    Pol Merkur Lekarski; 2007 Aug 10; 23(134):95-9. PubMed ID: 18044336
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The impact of immunosuppression on erythema migrans. A retrospective study of clinical presentation, response to treatment and production of Borrelia antibodies in 33 patients.
    Fürst B, Glatz M, Kerl H, Müllegger RR.
    Clin Exp Dermatol; 2006 Jul 10; 31(4):509-14. PubMed ID: 16716151
    [Abstract] [Full Text] [Related]

  • 20. Sensitivity of culture and polymerase chain reaction for the etiologic diagnosis of erythema migrans.
    Zore A, Ruzić-Sabljić E, Maraspin V, Cimperman J, Lotric-Furlan S, Pikelj A, Jurca T, Logar M, Strle F.
    Wien Klin Wochenschr; 2002 Jul 31; 114(13-14):606-9. PubMed ID: 12422609
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.